Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma Response and Biology-Based Risk factor-guided therapy in treating younger patients with non-high Neuroblastoma

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Non-high-risk Neuroblastoma
  • Age: Between 0 - 18 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:

    1. Patients must be < 12 months (< 365 days) of age at diagnosis with INRG Stage L1; or < 18 months (< 547 days) of age at diagnosis with INRG Stage L2 or Stage Ms neuroblastoma/ganglioneuroblastoma.


    2. Patients must have newly diagnosed MYCN non-amplified neuroblastoma (ICD-O morphology 9500/3) or MYCN non-amplified ganglioneuroblastoma verified by histology.


    3. No prior radiotherapy or chemotherapy, with the exception of dexamethasone

You may not be eligible for this study if the following are true:

  • 1.  Patients with MYCN amplified tumors are not eligible

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.